Important:
Therapy notes
Important:
Formulation and dosage details
Formulation:
Tablets 30mg, 60mg, 90mg (s)
Dosage:
Treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy: initially 30mg once daily adjusted every 2 to 4 weeks to maximum 180mg daily.